Print Page     Close Window     

SEC Filings

20-F
IKANG HEALTHCARE GROUP, INC. filed this Form 20-F on 08/10/2018
Entire Document
 

Table of Contents

 

IKANG HEALTHCARE GROUP, INC.

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued

FOR THE YEARS ENDED MARCH 31, 2016, 2017 AND 2018

(In thousands of US dollars, except share and per share data, or otherwise noted)

 

8.                                      ACQUIRED INTANGIBLE ASSETS, NET

 

The gross carrying amount, accumulated amortization, impairment and net carrying amount of the intangible assets are as follows:

 

 

 

As of March 31,

 

 

 

2017

 

2018

 

 

 

 

 

 

 

Acquired intangible assets not subject to amortization

 

 

 

 

 

Trade-name

 

$

10,486

 

$

11,721

 

Acquired intangible assets subject to amortization

 

 

 

 

 

Customer relationship

 

36,913

 

41,077

 

Operating licenses

 

5,371

 

5,942

 

Favorable lease contracts

 

1,733

 

1,886

 

Contract backlog

 

79

 

87

 

Non-compete agreements

 

451

 

446

 

 

 

55,033

 

61,159

 

Less: accumulated amortization

 

 

 

 

 

Customer relationship

 

23,946

 

32,873

 

Operating licenses

 

3,277

 

3,988

 

Favorable lease contracts

 

1,043

 

1,350

 

Contract backlog

 

79

 

87

 

Non-compete agreements

 

451

 

446

 

Less: impairment

 

385

 

422

 

Intangible assets, net

 

$

25,852

 

$

21,993

 

 

Amortization expenses for the years ended March 31, 2016, 2017 and 2018 were $10,769, $9,853 and $7,210, respectively. Amortization expenses for the years ending March 31, 2019, 2020, 2021, 2022, 2023 and thereafter would be $4,784, $2,785, $1,024, $209, $142 and $839, respectively. No impairment loss was recognized on acquired intangible assets during the years ended March 31, 2016, 2017 and 2018, respectively. The change of impairment is caused by the exchange rate difference.

 

9.                                      LONG-TERM INVESTMENTS

 

The Group’s long-term investments consist of cost method investments, equity method investments and available-for-sale investments.

 

 

 

As of March 31,

 

 

 

2017

 

2018

 

 

 

 

 

 

 

Cost method investments (1)

 

$

46,724

 

$

50,626

 

Equity method investments (2)

 

127,233

 

138,330

 

Available-for-sale investments (3)

 

6,801

 

7,860

 

 

 

$

180,758

 

$

196,816

 

 

F-38



Copyright © 2015- iKang Healthcare Group, Inc. All Rights Reserved.